Previous 10 | Next 10 |
Valneva ( NASDAQ: VALN ) ( OTCPK:INRLF ) ( OTC:VNVLF ) reduced its FY22 revenue outlook citing reduced demand for its COVID vaccine from the EU member states. COVID-19 vaccine sales in H1 were €3.8M. However, Valneva recorded an operating loss of...
Approximately 6,000 participants 5 years of age and older will be enrolled in Lyme disease-endemic regions in Europe and the U.S. Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study...
Valneva is a specialty vaccines company with an ongoing travelers vaccine business. Two major catalysts are around the corner: a BLA for chikungunya vaccine and a Phase 3 trial for the world’s only Lyme vaccine candidate. The company is trading near the low end of its 52-we...
We are revisiting Dynavax Technologies after this vaccine concern just posted robust quarterly results that easily exceeded expectations. The company continues to gain market share with its Hepatitis B vaccine and is seeing huge revenue growth from its Covid-19 efforts. What's nex...
The European Commission announced an agreement with Valneva ( NASDAQ: VALN ) ( OTCPK:INRLF ) ( OTC:VNVLF ) on Wednesday that would sharply reduce the French biotech’s COVID-19 vaccine deliveries to the region this year. In late June, the commission approved ...
The health authorities in the EU have recommended a second COVID-19 booster shot for those aged 60 – 79 and medically vulnerable people who are at high risk of severe disease, the European Medicines Agency (EMA) said in a statement on Monday. In April, The European Centre for...
Pure play COVID-19 vaccine makers closed the 1H 2022 as some of the worst performers in the beaten-down biotech space amid concerns over how the group, once a pandemic favorite, could sustain growth as COVID impact wanes. The selloff, worse than the ~33% decline among biotech stocks...
Gainers: Agile Therapeutics (AGRX) +81%. Kezar Life Sciences (KZR) +75%. Decibel Therapeutics (DBTX) +21%. Sutro Biopharma (STRO) +16%. Bellerophon Therapeutics (BLPH) +11%. Losers: Scholar Rock (SRRK) -11%. NGM Biopharmaceuticals (NGM)...
French biotech Valneva (NASDAQ:VALN) announced on Friday that the European Commission (EC) granted marketing authorization for its inactivated whole-virus COVID-19 vaccine, VLA2001 for primary vaccination in those aged 18 – 50. The approval for VLA2001 marks the first time the regulato...
Gainers: Anebulo Pharmaceuticals (ANEB) +32%. Tenon Medical (TNON) +19%. PolarityTE (PTE) +14%. TRACON Pharmaceuticals (TCON) +14%. Bausch Health (BHC) +13%. Losers: BioSig Technologies (BSGM) -26%. Rigel Pharmaceuticals (RIGL) -8%. Valneva (VALN) ...
News, Short Squeeze, Breakout and More Instantly...
2024-06-25 09:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-03 18:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-24 20:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...